Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kellanova is a global leader in snacking and convenience foods. It was formed in 2023 as a spin-off from the former Kellogg Company to focus on global snacks, international cereal and noodles, plant-based foods, and North America frozen breakfast products. The company owns iconic brands such as Pringles, Cheez-It, Pop-Tarts, Eggo, Morningstar Farms (plant-based), RXBAR and more. In 2024 it reported net sales of approximately $13.4–$13.6 billion. In August 2024 it was announced that Mars would acquire Kellanova for $39.5 billion.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kellanova.